SCHEMBL5077904

SCHEMBL5077904

CON(C)C(=O)CCC1CCCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
BACE1 P56817 2/20 0.43
CTSD P07339 1/20 0.43
GLS O94925 2/20 0.42
CYP2C9 P11712 1/20 0.42
FEN1 P39748 2/20 0.41
SCN9A Q15858 1/20 0.41
ACKR3 P25106 1/20 0.41
HPGD P15428 1/20 0.40
FPR3 P25089 1/20 0.40
FPR2 P25090 1/20 0.40
KDM1A O60341 1/20 0.39
NR1H2 P55055 1/20 0.39
ALOX5AP P20292 1/20 0.38
CHEK2 O96017 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27406252 1.00 ALDH1A1 (0.46) ALDH1A1MEN1MAPTKMT2ABACE1
SCHEMBL16629044 0.87 NR1H2 (0.47) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL2547405 0.86 GPR119 (0.47) ALDH1A1HPGD
SCHEMBL20558210 0.83 ALDH1A1 (0.49) ALDH1A1MEN1MAPTKMT2ABACE1
SCHEMBL307201 0.82 MEN1 (0.51) ALDH1A1MEN1MAPTKMT2ABACE1
SCHEMBL13308546 0.82 MEN1 (0.51) ALDH1A1MEN1MAPTKMT2ABACE1
SCHEMBL13308544 0.82 MEN1 (0.51) ALDH1A1MEN1MAPTKMT2ABACE1
SCHEMBL5509262 0.81 MEN1 (0.50) ALDH1A1MEN1MAPTKMT2ABACE1
SCHEMBL7690285 0.81 ALDH1A1 (0.48) ALDH1A1MEN1MAPTKMT2ABACE1
SCHEMBL7686509 0.81 ALDH1A1 (0.48) ALDH1A1MEN1MAPTKMT2ABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945222-B1 PYRROLO[2,1-F] [1,2,4]-TRIAZIN-4-YLAMINES AS IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES Bayer Pharma AG (DE) 2012-12-26 EP disclosed
EP-1945222-A2 PYRROLO[2,1-F] [1,2,4] TRIAZIN-4-YLAMINES IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES Bayer HealthCare AG (DE) 2008-07-23 EP disclosed
WO-2007056170-A2 PYRROLO[2,1-F] [1,2,4] TRIAZIN-4-YLAMINES IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES BAYER HEALTHCARE AG (DE) 2007-05-18 WO disclosed